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Abstract 
Predictions of future cases of asbestos-related disease have been undertaken at a national level to inform 
government policy and planning for future health needs. In general, we can separate the methods used to 
predict future cases of mesothelioma into models that use a) direct or b) indirect estimates of asbestos 
exposure. Direct estimates are those that have been derived mostly for occupationally exposed cohorts, 
where airborne fibre levels were measured over time. Indirect estimates tend to be information about total 
or fibre-specific asbestos imports or use from a range of time points. Most predictions undertaken at the 
national level have predicted future cases for males only and assume that indirect estimates of asbestos 
consumption reflect occupational asbestos exposure. These models tend to fit the observed data 
reasonably well but have undergone several refinements in order to improve their fit. Fewer attempts have 
been made to predict cases of mesothelioma resulting from non-occupational asbestos exposure, and most 
have not subsequently revisited their prediction to ascertain its accuracy so the robustness of these 
methods is unclear. Because of the change in asbestos use in recent decades, more attention should be 
paid to understanding the risks and burden of future cases arising from non-occupational exposure. A 
range of current data exist that should be sufficient to incorporate into models to predict future cases of 
mesothelioma arising from non-occupational asbestos exposure. Models could be tested for their accuracy 
by comparing them against the most recent 10 years of observed cases or against cases in women, whose 
most common source of exposure is non-occupational. 
 
Predictions of the future burden of disease are undertaken for a variety of policy and 
planning reasons. Knowledge about the future number of cases of a particular disease 
can assist health planners to allocate resources for primary prevention, screening and 
diagnosis, treatment, and palliative care. Estimates of the future burden of disease can 
also be used to evaluate prevention programs. For example, the number of observed 
cases after the introduction of a prevention program could be evaluated against the 
number of expected cases, assuming that the disease trends before the program was 
introduced continued into the future. In the same vein, a prediction that estimated a 
heavy future burden of a particular disease could alert public health specialists to 
instigate a prevention program in order to avoid that prediction scenario (Bray and 
Moller 2006).  
The simplest type of cancer prediction extrapolates past trends of cancer incidence or 
mortality to some date in to the future, but more information is required in order to 
estimate more complex scenarios. Ideally, information about the effect of a risk factor 
on the cancer of interest would be known by sex and age group for the past, present and 
future. In addition, the prevalence of exposure to that risk factor in the population would 
also be known. This information would then be used to develop a statistical model that 
describes the relationship between the risk factor and the cancer rate. However, in 
reality, cancer is not associated with only one risk factor, and usually the prevalence of 
exposure in the population is unknown and risk factor data are not available at the level 
 The effectiveness of predictive models for mesothelioma 2 
required (e.g. by age group and sex and calendar time). The exception is lung cancer 
and smoking, where the effect of smoking on lung cancer is well known, as is the 
prevalence of exposure to smoking, often by age group, sex and calendar time. As such, 
predictions of lung cancer epidemics associated with smoking have been regularly 
estimated (Winkler et al. 2011; Yamaguchi et al. 1992; Pierce et al. 1991) and have 
been shown to be reliable. For example, among Finnish males the observed incidence of 
lung cancer was shown to fit well with earlier predictions of lung cancer incidence 
estimated from hypothetical changes to smoking habits (Bray and Moller 2006; Moller 
et al. 2002). 
Predictions of asbestos-related diseases 
At a national level, predictions of future cases of asbestos-related disease have been 
undertaken to attempt to predict which year the peak number of cases may occur, after 
which the disease may then decline (Peto et al. 1995; Segura et al. 2003), and to inform 
government policy and planning for future health needs. Among occupational cohorts, 
predictions of future cases have been estimated to highlight the burden of disease in that 
cohort (de Klerk et al. 1989). They have also been undertaken to predict the future 
number of compensation claims resulting from people with mesothelioma caused by 
exposure to Johns Manville asbestos products (Stallard et al. 2005).  
Historically, asbestos exposure occurred among workers who worked with the raw 
asbestos, mining and milling it or processing it in textile or asbestos cement factories 
(Landrigan 1991). Subsequently, other workers, such as carpenters and plumbers, 
insulators, shipbuilders and railway workers, were exposed from their use of the 
manufactured asbestos product. Latterly, workers who maintain buildings or remove 
asbestos from buildings have the highest asbestos exposure potential (Frost et al. 2008). 
Non-occupational exposure occurred among family members of asbestos workers, who 
brought their clothes home for laundering or among those who lived nearby to an 
asbestos factory or who worked in a building that contained asbestos (Robinson 2012).  
Increasingly we need to turn our attention to the risks associated with, and the future 
burden of, asbestos-related diseases resulting from exposure to non-occupational 
sources of asbestos. Australia was an avid producer and consumer of asbestos. It was 
mined in Western Australia and New South Wales, and Australia also imported raw 
asbestos fibre and manufactured asbestos products, and manufactured its own asbestos 
cement products and asbestos goods.  
More than 60 percent of production and 90 percent of consumption of raw asbestos 
was by the asbestos cement manufacturing industry (Hughes 1978). Asbestos cement 
products, specifically fibro sheeting, were used largely as a building material for 
industrial and commercial premises, and as cladding for the outside of residential 
housing or as water and drainage piping, roofing shingles, guttering, and fencing 
throughout Australia. Asbestos was also used as an insulation material (e.g. Mr Fluffy 
homes in Canberra). The post-World War II housing boom until the 1960s saw 25 
percent of all new homes built in Australia (52 percent in NSW) clad in asbestos 
cement, and up to 70 percent contained some form of asbestos (National Occupational 
Health and Safety Commission 2004). Because of this Australia has a large amount of 
in situ asbestos in variable condition, throughout the built environment. Less is known 
about the risk of disease associated with exposure to in situ asbestos, largely in the form 
of asbestos cement. However, cases of mesothelioma have developed among do-it 
yourself home renovators (Olsen et al. 2011), and there are numerous reports of cases 
resulting from low dose asbestos exposure (Bourdes et al. 2000; Magnani et al. 2001). 
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Similarly, there is no known asbestos exposure threshold below which risk of disease 
does not occur (Iwatsubo et al. 1998). What is known is that the number of people 
exposed to in situ asbestos in Australia is probably very large, but the amount they have 
been exposed to, in most circumstances, is likely to be very low. Predictions of the 
future burden of asbestos-related disease that may emerge from low dose asbestos 
exposure might provide some insight about how best to manage the remaining in situ 
asbestos in Australia. For example, the future disease burden can be modelled against a 
range of prevention scenarios to inform policymakers about which prevention strategies 
would have the greatest impact (e.g. result in the fewest cases of mesothelioma). A 
particular comparison could be the future burden of mesotheliomas resulting from low 
dose asbestos exposure if in situ asbestos were removed as a priority from all 
government, commercial and domestic residences in Australia; or from only 
government and commercial premises; or if removal was not prioritised but in situ 
asbestos was contained. Furthermore, understanding the size of the possible future 
burden of asbestos-related disease can inform future health planning, budget allocation 
for screening and diagnosis, treatment, and palliative care.  
In the subsequent sections, a definition of asbestos and asbestos-related diseases is 
presented, and a discussion of the multi-stage model of carcinogenesis that has been 
used as the basis for many of the prediction methods. A discussion of different methods 
used to predict future cases of asbestos-related diseases follows. 
Asbestos 
Asbestos is the commercial name of a number of naturally occurring minerals that have 
crystallised to form long thin fibres and fibre bundles. There are two family types of 
asbestos: amphibole and serpentine. There are at least five varieties of amphiboles: 
crocidolite (blue asbestos), amosite (brown asbestos), actinolite, tremolite, and 
anthophyllite. Crocidolite fibres generally have the finest diameter. Amosite fibres are 
slightly thicker, and the less commercially used varieties of actinolite, tremolite, and 
anthophyllite are coarser (Roggli and Coin 1992). Chrysotile (white asbestos) is from 
the serpentine group of minerals and has been the most common commercially used 
form of asbestos.  
Asbestos-related diseases 
The inhalation of asbestos fibres is associated with both benign and malignant diseases. 
Asbestosis (diffuse interstitial pulmonary fibrosis) is a fibrosis of the lungs, and patients 
with well-established asbestosis present with symptoms of shortness of breath and a dry 
cough. It is a progressive but not necessarily fatal disease (Doll and Peto 1985). 
Asbestosis generally develops after heavier exposure, although the minimum amount of 
asbestos exposure needed to cause asbestosis is unclear. Other benign conditions 
associated with asbestos exposure include discrete plaques and pleural calcification, 
diffuse pleural thickening and thickening of the interlobar fissure (Reid et al. 2005).  
Cancers associated with asbestos exposure include malignant mesothelioma, which 
presents as a diffuse involvement of a mesothelial surface, most commonly in the pleura 
and less frequently in the peritoneum, pericardium and testes. It is universally fatal, with 
a median survival period of between nine and twelve months (Musk et al. 2011). All 
four major histological types of lung cancer (adenomatous, squamous, undifferentiated 
large-cell, and small-cell carcinoma) are related to asbestos exposure. Other cancers 
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caused by asbestos include cancers of the larynx, and there is inconsistent evidence for 
cancers of the colon and rectum, stomach and pharynx (Straif et al. 2009). Ovarian 
cancer has been associated with asbestos exposure (Straif et al. 2009), although there is 
some doubt that this may be peritoneal mesotheliomas misdiagnosed (Reid et al. 2011). 
Malignant mesothelioma has a long latency period (the period of time that has passed 
since first asbestos exposure to the onset of the disease or death), rarely developing 
within 15 years since first exposure (Antman and Aisner 1987), yet increasing with time 
since first exposure for up to 45 years for pleural, and longer for peritoneal, 
mesothelioma (Reid et al. 2014). Mesothelioma mortality rates have been found to be 
proportional to the 3
rd
 or 4
th
 power of time since first exposed to asbestos (Peto et al. 
1982).  
Multi-stage model of carcinogenesis  
Multi-stage models of carcinogenesis attempt to describe the biological processes 
involved in cancer development in mathematical and conceptual terms. The simplest 
model was proposed by Armitage and Doll in 1954 to explain the observation that age-
specific cancer incidence curves increased linearly with age (Armitage and Doll 2004). 
Plotting the logarithm of incidence against the logarithm of age resulted in a straight 
line with a slope between four and five (Breslow and Day 1987). For many cancers this 
model represented the background age specific rate, and k (power of time since first 
exposure) was equal to five or six (Breslow and Day 1987). The basic premise of the 
Armitage/Doll model was the assumption that cancer develops from a single normal cell 
that has undergone a series of transitions. The occurrence of the last transformation 
leads to cancer in that cell. The number of cells at risk at the start is assumed to be large, 
but the probability of the critical number of transformations occurring in any individual 
cell is considered to be small (Breslow and Day 1987). If this model were true, most 
cancers would develop after the cell has undergone five or six transformations towards 
malignancy (Kaldor and Day 1996).  
For mesothelioma, mortality rises rapidly with increasing time since first exposure 
and is independent of age (Peto et al. 1982). These observations are best explained by a 
dose-response model (the mesothelioma mortality rate model), where the increase in 
subsequent mesothelioma risk is proportional to the cumulative dose inhaled, to a power 
of time since first exposure lying between three and four, and to a latency period of ten 
years before mortality begins to increases (Peto et al. 1982). Later work has further 
refined this model and includes parameters that allow for the clearance of fibres from 
the lungs (Berry 1999). The mesothelioma rate model is expressed as:  
Mesothelioma rate = ce
-λt
(t – w)k  
where ce is cumulative exposure, t is time since first exposure, w is the lag period, k 
is the power of time since first exposure, and λ is the rate of clearance of asbestos fibres 
from the lung. 
Literature search procedure 
To identify the literature predicting future cases of asbestos-related disease, the 
following search terms were searched singly and together: asbestos, prediction, 
projection, forecasting, mesothelioma, mesothelioma mortality, asbestosis, exposure, 
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environmental exposure, age-period-cohort models, risk models, mesothelioma 
mortality rate. The search was conducted through online databases including the Public 
Library of Medicine, Web of Science, and the Curtin University library catalogue. 
Bibliographies of papers were also examined. The search was not time delimited, but 
this review focuses more heavily on more recent prediction methods, most of which 
derive from the earliest methods used. Prediction methods used for occupational cohorts 
that have individual estimates of asbestos exposure were not the focus of this review, 
but the total exclusion of that method would have made explanation of other methods 
used difficult. Therefore one paper outlining a prediction method which formed the 
basis for many subsequent predictions has been included (Berry 1991). 
Many of the prediction methods outlined below attempt to use the mesothelioma 
mortality rate model in their methods. The extent to which they can do this depends 
largely on the availability and quality of data about asbestos exposure. In general, we 
can separate the methods used to predict future cases of mesothelioma into models that 
use direct or indirect estimates of asbestos exposure (Stallard et al. 2005). Direct 
estimates of asbestos exposure are those that have been derived mostly for 
occupationally exposed cohorts where airborne fibre levels were measured over time, 
e.g. the Wittenoom workers where each worker had an exposure based on their job and 
the length of time in that job (Armstrong et al. 1988). Indirect estimates of asbestos 
exposure tend to be information about total or fibre-specific asbestos imports, or use 
from a range of time points. In the epidemiology literature, prediction methods that 
incorporate information about direct and indirect asbestos exposure are called 
predictions, while those that do not incorporate any information about asbestos 
exposure are referred to as projections. 
Models based on direct estimates of asbestos exposure  
Prediction methods that use direct estimates of asbestos exposure have been used to 
predict future cases of malignant mesothelioma among cohorts with known estimates of 
quantitative asbestos exposure, mostly occupational exposure. For example, among 
Wittenoom crocidolite miners and millers (de Klerk et al. 1989) (Berry 1991; Berry 
1999; Berry et al. 2012), or among the women who lived at Wittenoom who were non-
occupationally exposed to asbestos (Reid et al. 2009), albeit at quite high levels. 
Similarly, this model was used to predict cases of mesothelioma among Italian railway 
workers with known estimates of asbestos exposure (Gasparrini et al. 2008). 
The method involves calculating the mortality rate for the cohort to establish the 
excess deaths from all causes of death, lung cancer and mesothelioma in the cohort 
compared with the unexposed population. Then maximum likelihood estimates for the 
mesothelioma rate parameters ce, k and λ are derived from the cohort data, although 
because of correlation between k and λ, λ is often fixed at 6.7 percent and 15 percent per 
annum, and only k estimated (Reid et al. 2009). All of this information provides the 
probability of dying in a year, averaged over each age. This is then applied to the 
number of surviving workers in a particular year to estimate the number who survive to 
the end of the next year, using a lifetable-type approach. For example, applying the 
probability of dying in a year to workers who are still alive at the end of 2015 estimates 
the number of workers who will be alive at the end of 2016. Subtracting the number of 
survivors in 2016 from those in 2015 gives the number of deaths for 2016. The number 
of mesothelioma deaths each year can be calculated by multiplying the mesothelioma 
death rate with the number of surviving workers in each year (Berry 1991).  
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 Several studies have compared their earlier predictions against observed data and 
have found a good fit. For example, Berry et al. used five different mesothelioma 
models, based on different lag times (0, 5 and 10 years) and rates of elimination of 
asbestos fibres (6.7 percent and 15 percent per annum). They predicted between 250 and 
680 cases of mesothelioma among former Wittenoom workers between 1987 and 2020 
(Berry 1991). Subsequent revisiting of this prediction showed that the model that 
incorporated an elimination rate of 15 percent and a lag period of five years had a good 
fit with the observed data (Berry et al. 2004).  
Prediction methods that incorporate individual level data on asbestos exposure 
should be seen as the ‘gold standard’ for prediction methods. They are more accurate 
than other methods because they are based on exact information about demographic 
characteristics, period of exposure, and cumulative exposure (Gasparrini et al. 2008). 
But because of the high level of data required they are only capable of being used to 
predict future disease in a small range of situations, e.g. among workers in specific 
occupations or industries. Most mesothelioma predictions have been undertaken where 
direct measures of asbestos are not available, e.g. at the national or regional level where 
direct exposure estimation would be impossible. 
Models based on indirect measures of asbestos exposure  
Age-cohort models and age-period-cohort models 
Age-cohort (AC) models and age-period-cohort (APC) models have been the method 
used most often to predict future cases of mesothelioma where direct measures of 
asbestos exposure are unknown. Most commonly they have been used to predict future 
cases among whole populations, e.g. for Britain (Peto et al. 1995) or for the Netherlands 
(Segura et al. 2003). They have also been used to estimate future disease compensation 
claims among former Johns Manville asbestos cement workers and those exposed to 
Johns Manville asbestos products (Stallard et al. 2005).  
AC/APC models analyse the effects of age at diagnosis or death, birth cohort, and 
period of diagnosis or death on the past mesothelioma rates (Marinaccio et al. 2005). 
The information on mesothelioma cases usually comes from a mesothelioma or cancer 
registry or from a mortality registry. The mesothelioma rates (cases of 
mesothelioma/population at risk) are organised into age at diagnosis or death groups 
(usually 5 year age groups e.g. 20–24, 25–29, … 75–79), period of diagnosis or death 
groups (again, usually 5 year period groups e.g. 1970–74, 1975–79, … 2010–14), and 
10 year birth cohort groups. Then, in general, a log linear Poisson regression model is 
fitted to the age-specific mesothelioma rates to estimate the effects of age and birth 
cohort and period of death on the mesothelioma rates, and to estimate the relative risk of 
mesothelioma for each birth cohort. To predict future cases of mesothelioma, the 
relative risk for the latest period (e.g. 2010–14) is applied for single or grouped years of 
age to the projected age-specific population.  
The earliest predictions of mesothelioma cases at a national or country level were 
undertaken using models in which mesothelioma risk was related independently to age 
at death or diagnosis with mesothelioma and date of birth. These models predicted 
proportional hazards across the different birth cohorts. Asbestos exposure was assumed 
to be proportional to asbestos imports and was accounted for indirectly by measuring 
time in birth cohorts (M. Clements et al. 2007). Several predictions for national 
countries were undertaken using this method and for some of these, subsequent studies 
revisited the earlier prediction and examined the fit of the prediction against the number 
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of cases that actually occurred. For Great Britain, between 2700 and 3300 male 
mesothelioma deaths were predicted to peak in the year 2020 (Peto et al. 1995). 
Subsequent work showed that this model fit the data reasonably well until 1991, but 
showed a departure from the fit with later cohorts, predicting more cases of 
mesothelioma than actually occurred among those later birth cohorts. Similarly, 
predictions of mesotheliomas in Europe (Peto et al. 1999) and the Netherlands (Peto et 
al. 1999), when subsequently revisited, overestimated the number of cases (Pelucchi et 
al. 2004; Segura et al. 2003). This was largely because the mesothelioma rate did not 
increase as fast with increasing age in the younger cohorts as it did in the older cohorts. 
More recent birth cohorts would only have been exposed to asbestos early in their 
working life so it is unclear whether the risk of mesothelioma would continue to 
increase with age up to 80 years or whether it will flatten out at younger ages for these 
cohorts (Clements et al. 2007). These methods did not take into account any period 
effects on the mesothelioma rate. For example, they couldn’t account for the lower 
asbestos exposure experienced by the younger cohorts, after asbestos bans and exposure 
standards were introduced in the 1970s (Gasparrini et al. 2008). The AC method 
assumed that the rate increased at the same rate by age for all cohorts and so was 
unreliable (Hodgson et al. 2005).  
In light of these limitations subsequent work undertook predictions at a national level 
using APC models that included a priori assumptions about period effects (Gasparrini 
et al. 2008). For example, based on the large reduction in the use of asbestos in the 
Netherlands from 1984, Segura et al. (2003) assumed that the risk of mesothelioma 
among those born between 1958-62 was 50 percent less than that of those born between 
1953–57. Similarly, birth cohorts born after 1962 were assumed to have zero risk of 
mesothelioma. To this same model a period effect was incorporated, to account for the 
introduction of the International Classification of Diseases – Volume 10 (ICD-10), 
which greatly improved the recording of mesothelioma on death certificates. Compared 
with the earlier prediction of approximately 1000 deaths in the peak year of 2020 (Peto 
et al. 1999), this enhanced model predicted a peak year of 2017 and 501 deaths (Segura 
et al. 2003). However, the accuracy of this later method for predicting future 
mesotheliomas has not been assessed against observed data. 
Other work has incorporated Bayesian statistical methods into APC models to make 
inferences from past knowledge to improve the fit of these models to identify the 
relative contribution of age, period and cohort on the risk of mesothelioma (Girardi et 
al. 2014; Pitarque et al. 2008). However, subsequent work comparing the observed 
cases against predictions found that the Bayesian enhanced APC model used by 
Pitarque et al. (2008) underestimated observed mesotheliomas by 41 percent or 261 
deaths (López-Abente et al. 2013).  
The APC model has also been used to project future cases of mesothelioma using a 
method that does not require knowledge about asbestos exposure (Martínez Miranda et 
al. 2015). The statistical model is estimated with Poisson regression without an offset, 
so is somewhat simpler to model than the more sophisticated APC models that use the 
log-linear method. The authors suggest that their method can be used to benchmark 
more sophisticated prediction models. Compared with other predictions for Great 
Britain, this method projected a peak in 2018 of 2095 (95% CI 1978–2210) cases. This 
compares favourably with Peto’s 2700 peak cases in 2020 (Peto et al. 1995), Hodgson’s 
1846 cases peaking in 2013 (Hodgson et al. 2005) and Tan’s 2040 deaths peaking in 
2016 (Tan et al. 2010). The latter two prediction methods (see below) involved 
complicated constructions of exposure. 
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Other factors that may have influenced mesothelioma rates but that were generally 
not accounted for in APC models include improvements in the diagnosis and reporting 
of mesothelioma over time, where earlier cases may have been missed. A further 
limitation of these methods is that the analyses were based on the age-cohort 
distribution of the general population, whereas the mesothelioma cases will mostly 
come from specific occupational populations (Gasparrini et al. 2008) such as carpenters 
and asbestos textile workers. Also, many of these models predicted future cases among 
men only, because asbestos consumption records are an indicator of the use of asbestos 
exposure that men would incur in certain jobs, whereas women are more likely to obtain 
their asbestos exposure from sources other than work, e.g. from the general environment 
or take-home asbestos. These models tend to predict cases from high exposure scenarios 
only and do not take into account risks from lower exposure. In addition, clearance of 
asbestos fibres from the lung was increasingly found to be important for the risk of 
mesothelioma, and this had not been accounted for (Berry 1999).  
Other models  
Hodgson et al. (2005) attempted to improve the accuracy of mesothelioma predictions 
in Great Britain and used a model that related current mesothelioma mortality to past 
asbestos exposure, and also accounted for the clearance of asbestos fibres from the 
lungs and for the completeness of mesothelioma diagnosis over time. Similar to the 
earlier models, indirect asbestos exposure was dependent on calendar year, but unlike 
earlier AC models, it varied with age. This overcame the limitation of earlier models 
that assumed that the mesothelioma rate increased by age for all cohorts (Hodgson et al. 
2005). When compared against observed cases of mesothelioma, the enhanced model fit 
the data better than the earlier, simpler models and predicted fewer mesotheliomas, 
around 1950-2450 deaths, peaking between 2011 and 2015 (Hodgson et al. 2005). 
Confidence intervals for the model parameters and predictions could not be estimated in 
this enhanced model, so there remained a level of uncertainty in the predicted numbers 
(Clements et al. 2007; Hodgson et al. 2005; Tan et al. 2010). Further refinement to the 
model integrated a Bayesian statistical analysis that allowed for data on asbestos 
imports and levels of asbestos use, and a background rate of mesothelioma, to be 
included in the model and the calculation of credible and prediction intervals, thus 
providing a measure of uncertainty. Compared with observed cases between 1968 and 
2006, this refined method fit the observed data well and predicted fewer mesotheliomas 
than the earlier methods, peaking at 2038 male deaths (prediction interval 1929–2156) 
in 2016 (Tan et al. 2010). To date the predicted cases from this method have not been 
compared against observed data.  
A similar model to that proposed by Hodgson was used to predict future cases of 
mesothelioma in New South Wales (Clements et al. 2007). This method differed to the 
former through the use of natural splines as the parameters for change in asbestos 
exposure by time and age, and assumed that birth cohorts born after 1970 had negligible 
risk for mesothelioma.  
Other authors have used risk function models that are very similar to the models used 
to predict mortality in the occupational cohort studies discussed above, but with indirect 
measures of asbestos exposure. Banai et al. (2000) predicted future cases of 
mesothelioma for the population of French men, who generally had much lower 
exposure than those other cohorts. This model incorporated a risk of death at a given 
age as well as a risk function for the mesothelioma mortality rate, and data from past 
French asbestos imports was used to model overall past asbestos exposure. Their results 
were very comparable to earlier work that had used the age-cohort method to predict 
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future mesothelioma cases (Ilg et al. 1998). Using a risk function model based on that 
used by Banai et al (2000), but adapted for Japanese circumstances, Myojin et al (2012) 
predicted future cases of mesothelioma in Japan, and only for those who worked in 
construction and manufacturing rather than the whole population of men. It is unclear 
how this method fits against observed cases.  
Predictions of other asbestos-related diseases 
Future cases of asbestosis and lung cancer have been predicted far less frequently than 
malignant mesothelioma, although the method used to predict these other asbestos-
related diseases was similar to those outlined above for mesothelioma. For lung cancer 
there is an added complication that while most mesotheliomas are accepted as being 
caused by asbestos exposure, the proportion of asbestos-related lung cancers is less 
clear, and not clinically distinguishable from those due to other causes – therefore it 
must be estimated (Darnton et al. 2006). One such estimation provided a ratio of the 
number of asbestos-related lung cancers per mesothelioma death, where mesothelioma 
death was used as a proxy for asbestos exposure and based on data from 55 asbestos 
exposed cohort studies. The ratios varied by fibre type, and ranged from 0.7 (95% CI 
0.5–1.0) for crocidolite, 6.1 (3.6–10.5) for chrysotile, 4.0 (2.8–5.9) for amosite, and 1.9 
(1.4–2.6) for mixed fibres (McCormack et al. 2012).  
Following on from this work, three prediction methods were used to estimate future 
lung cancers related to asbestos exposure in the Netherlands (Van der Bij et al. 2016). 
The first method estimated lung cancers from predicted mesotheliomas using the ratio, 
based on exposure to mixed fibre types, of 1.5 asbestos-related lung cancers per 
mesothelioma death, as suggested by McCormack et al (2012). The second method 
applied, from an earlier study, the fraction of lung cancer cases attributable to asbestos 
exposure (PAR population attributable risk) to the predicted number of lung cancers 
derived for the period 2011–30 and the projected male demographic distribution 
between 2011 and 2030. This predicted number of lung cancers was derived from lung 
cancers observed between 2008–10. The third method used exposure information and 
asbestos-related lung cancer risk as a function of that exposure to estimate the future 
lung asbestos-related lung cancers in a lifetable analysis. The three methods varied 
widely in their future predictions, from a high of 17,500 for method one, to 12,150 for 
method two, and 6800 for method three. They were unwilling to state which method 
they thought was the most accurate, instead commenting that the robustness of any 
method relies heavily on the quality of the information put into it and that the most 
comprehensive method is not necessarily better than a simple one (Van der Bij et al. 
2016). 
Work from the United States predicted future deaths from asbestosis among US 
residents, using past deaths from asbestosis and asbestos consumption
1
 per capita as an 
indirect estimate of asbestos exposure (dos Santos Antao et al. 2009). They found that 
the model that best fit deaths from asbestosis between 1968 and 2004 used asbestos 
consumption per capita 48 years prior (1920–56), and used this model to predict future 
deaths from asbestosis (dos Santos Antao et al. 2009). However, predicted cases have 
not been revisited to compare against observed cases to determine the accuracy of their 
model. 
Future cases of lung cancer have been estimated among cohorts of workers exposed 
to asbestos (Berry 1991; de Klerk et al. 1989; Gasparrini et al. 2008), using methods 
                                                 
1 Asbestos production, plus imports, minus exports, minus changes to government and industry stocks 
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similar to those reported above that used direct estimates of asbestos exposure, but 
where a rate for lung cancer mortality was derived instead of a rate for mesothelioma. 
None of these predictions have been revisited to compare against observed data.  
Predictions of mesothelioma from non-occupational exposure 
Most of the prediction methods discussed above considered mostly men, and 
occupational and high-dose exposure only. Increasingly, cases of mesothelioma have 
been occurring among people with low-dose non-occupational asbestos exposure, but to 
date little attention has been paid to the future burden of mesothelioma from low-dose 
exposure. There are still considerable gaps in our understanding of the risks associated 
with non-occupational asbestos exposure, and the prevalence of that exposure within the 
population. 
In terms of knowledge, we are uncertain about the dose-response relationship for 
asbestos-related disease in persons with low dose exposure, particularly the risks 
associated with domestic or residential exposure. Where information on low dose 
exposure risk exists, it tends to be from cohorts of people that would have had 
considerably higher asbestos exposure than that emanating from the built environment. 
For example, the women from the blue asbestos mining and milling town of Wittenoom 
were not exposed to asbestos occupationally, but their environment was highly 
contaminated from mine tailings being distributed around the town (Reid et al. 2008a; 
2008b).  
At the same time we are uncertain about the amount of asbestos product that remains 
in the built environment and the condition of that asbestos product, although we do have 
estimates of the amount of asbestos used and removed over time in Australia (Finity 
2016). However, we are uncertain as to its location and uncertain about the amount 
(level) of exposure that comes from that source of asbestos – although earlier work from 
the UK and US reported very low levels of asbestos inside buildings that contained 
asbestos in varying conditions (Burdett et al. 1988; Crump and Farrar 1989). We are 
also uncertain about who or how many in the population have been exposed to asbestos 
from this source.  
Three studies have been identified that predicted future burden of mesothelioma 
among those exposed non-occupationally. Azuma et al. (2009) used a model based on 
the mesothelioma mortality rate model and indirect measures of asbestos exposure to 
predict future cases resulting from environmental exposure in Japan. This study defined 
environmental exposure in its narrowest sense, being only that exposure that was not 
occupational, domestic or from indoor asbestos exposure (e.g. being exposed to 
asbestos in a room where sprayed asbestos was used). Their model included a parameter 
for the annual average concentration of asbestos in years, and another for continuous 
asbestos exposure. The annual average concentration of airborne asbestos in years was 
estimated from a range of sources in the literature, including trend data for commercial 
areas beginning in 1981, and exposure measurements from 1968 and 1970. In addition, 
national field surveys assessing levels of airborne asbestos concentrations were 
conducted in 1985 and 2005. Estimates were supported from data on the consumption 
of sprayed asbestos as well as trends in the number of ferruginous bodies detected in the 
lungs of the general population. Their model fitted well against observed cases of 
mesothelioma resulting from exclusive environmental asbestos exposure. However, the 
robustness of this method is unclear, sensitivity analyses comparing a range of exposure 
scenarios were not conducted, and the predicted cases have not been examined against 
observed data.  
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Furlan and Mortarino (2012) predicted future cases of mesothelioma among residents 
of the Local Health Area (LHA) of Casale, which contains the city of Casale 
Monferrato, where Italy’s largest asbestos cement factory was located. Other work had 
shown an increased risk of mesothelioma among residents of the LHA (Magnani et al. 
1995). Their method was based on one used for epidemic diseases and predicted a total 
number of deaths and a date for the end of the ‘epidemic’. Information on the number of 
individuals who incurred the same exposure (e.g. the number of people who lived in the 
LHA at the same time) was needed, rather than individual level asbestos exposure. They 
predicted future cases in three areas: (1) among residents of the city of Casale 
Monferrato; (2) in residents of Casale Monferrato and bordering towns; and (3) in the 
Casale Local Health Area. Their model predicted fewer cases with increasing distance 
from the asbestos cement factory. Confidence intervals were built for each area, and 
uncertainty about the number of future cases and the end period of the ‘epidemic’ in the 
larger area (LHA) was greatest. One strength of this method was that it could predict 
future disease among all residents of these areas and not only those who worked for the 
factory. However, the data requirements were large for this method, and the modelling 
included several assumptions that had large impacts on the outcomes and uncertainty of 
the results.  
For Australia, Finity (2016) predicted the future burden of mesothelioma by wave of 
asbestos exposure. Waves 1 and 2 were defined as cases where exposure was from 
asbestos mining, manufacture and heavy industrial use and asbestos product use, 
particularly in the building industry. Also included in Waves 1 and 2 were those cases 
where exposure was from living near an asbestos cement factory or from asbestos 
brought home on workers’ clothes. Wave 3 cases were defined as those where exposure 
was from asbestos in the built environment, e.g. from disturbing or renovating a home 
that contained asbestos, background cases, and occupational exposure post-2003 (the 
year Australia banned all types of asbestos). Finity (2016) used a mesothelioma risk 
model that predicted the future burden for each exposure wave. To account for asbestos 
exposure over time, an asbestos volume index was derived based on 100 percent weight 
for the amount of national asbestos consumption plus a 30 percent weight for the 
amount of asbestos removed nationally, and reflecting the changing use of asbestos 
types over time and safe handling procedures. The exposure index was based on the 
volume of asbestos consumed rather than the number of people exposed. Also included 
in the model were parameters for age at first exposure and duration of exposure. 
Exposure duration of 2 years was allocated to Wave 3, assuming a shorter exposure 
period for a home renovation. The Australian mortality rate and projected population to 
2100 were taken from Australian life tables. The model was back-fitted against 
observed cases from 1988-2014 for each wave separately and together, and showed a 
good fit for all exposure waves. Similarly, the projected peak of cases across all 
exposure sources combined closely matched two other predictions that used an APC 
model with natural cubic splines (Clements et al. 2007; Soeberg et al. 2016). However, 
Finity (2016) allocated a duration of exposure of 2 years for Wave 3 cases, which may 
be appropriate for those who obtained their exposure from DIY home renovation, but is 
likely to underestimate the duration of exposure among those who lived in a house 
containing ACM for many years. 
These three studies highlight the wide range of data used to undertake a prediction of 
future cases of non-occupationally exposed mesothelioma. To date none of these 
methods have been assessed against future observed cases, so how accurate they are at 
predicting future cases is uncertain.  
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Discussion 
As discussed above, most predictions of asbestos-related disease have been undertaken 
on men and largely based on high-dose occupational exposure. However, as the pattern 
of use of asbestos has changed in recent decades, so have the risks of exposure in 
relation to who is exposed and to how much. Therefore we need to improve our 
understanding about the risks associated with, and the future burden of, diseases 
resulting from exposure to non-occupational sources of asbestos. Specifically, we need 
to determine if the models used to predict occupational cases of mesothelioma can be 
used to accurately predict non-occupational cases, and if existing information about 
current non-occupational exposure is sufficient to include in those models.  
As the risk of mesothelioma is proportional to the dose of exposure, information 
about total asbestos exposure (indirect exposure), rather than individual level exposure 
information, should be sufficient to include in a prediction model of future cases of non-
occupational exposure. Indeed, Clements et al. (2007b) argue that where exposure data 
is poor, indirect methods are now state of the art for population level predictions. 
Estimates of national asbestos consumption have been used to provide information 
about the period and duration to which workers might have been exposed to asbestos in 
their occupation. However, this is less informative about the period and duration of 
exposure for people exposed subsequently to in situ asbestos, and should be tested in a 
range of prediction scenarios to assess its reliability for inclusion in non-occupational 
exposure prediction models. Alternatively a national survey could be conducted to 
estimate the proportion of the population that have been or currently are exposed to 
asbestos from their built environment – but seeking information about self-reported 
exposure is difficult, unreliable and costly. Also it is not clear by how much the estimate 
of predicted cases would change if detailed exposure information were available, or 
whether the hypothesized increase in precision justifies the cost of collecting new non-
occupational asbestos exposure data.  
 Other data do exist that may be used to inform future predictions. The Australian 
Mesothelioma Registry (AMR) may be a source of information to derive mesothelioma 
rates based on domestic/residential exposure. They have collected occupational and 
environmental asbestos exposure on new cases in Australia since 1980 (Leigh and 
Driscoll 2003). However, collecting exposure information on cases diagnosed since 
2010 has been very problematic for the AMR, and they are currently achieving this on 
only 17 percent of new cases, although these cases have been examined and classed as 
representative of all newly diagnosed mesothelioma cases (Finity 2016). Moreover, 
because of the long latency of these diseases, exposure among past cases may not reflect 
what is occurring today. Because of the reduction in the level of exposure over time, it 
may not be useful as a base to project forward to predict future cases, although they do 
inform historical exposures.  
Current data on the potential exposure levels from DIY home renovations, the 
prevalence of exposure to DIY home renovation, and the risk of mesothelioma from 
DIY exposure, could be used to inform prediction models estimating the future burden 
from DIY home renovations. Asbestos fibres released during a range of DIY home 
renovation tasks that involve the removal or disturbance of asbestos cement sheeting 
have been recently quantified. In situations where there was minimal breakage of 
cement sheets and where power tools were not used, the exposure was low. However, 
tasks that involved breaking sheets or using power tools resulted in personal exposures 
above 0.02f/ml (Benke 2016). Information about the current prevalence of exposure to 
asbestos from DIY exposure comes from a study conducted in 2008 in New South 
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Wales, where 44 percent of participants reported renovating their home; 53 percent of 
those reported being a DIY home renovator and 61 percent of those self-reported having 
had asbestos exposure (Park et al. 2013). The risk of mesothelioma from DIY exposure 
was examined using data from the Western Australian Mesothelioma Register. To the 
end of 2008, 87 cases of mesothelioma (55 in men) were reported where DIY home 
renovation was the main source of exposure. Over time, the proportion of cases with 
this source of exposure had been increasing; from 2005–2008, 8.4 percent of male and 
36 percent of female cases reported DIY exposure (Olsen et al. 2011).  
This review identified that many of the prediction methods assessed the fit of the 
model by back-fitting their model against past observed cases. Most of the studies 
reviewed here have not revisited their model at a date in the future to assess how it 
performed against new cases. A new way of assessing the fit of a prediction model 
would be to create it as usual from past incident mesothelioma cases or deaths, but 
exclude the most recent 10 years of incident cases or deaths. Then the accuracy of the 
model could be tested to see how well it fitted the most recent 10 years of data. A 
limitation with this method is that the most recent ten years of incident cases would, in 
most situations, contain the greatest number of cases, due to the long latency period of 
these diseases. But predicting disease at a national level may permit sufficient cases for 
this method to be tested. Furthermore, several models could be derived, each based on 
different existing data about current and past asbestos exposure. Each model could then 
be tested against the most recent 10 years of incident cases and compared, to inform on 
the impact of the exposure data on the estimate. From this comparison we will learn 
whether more asbestos exposure data needs to be collected, given the inherent 
difficulties and cost associated with collecting such data, or whether the existing data is 
sufficient for incorporating into future predictions.  
Another gap identified in this review was that many of the predictions excluded 
women from their estimates, in general because of their small number of cases. 
However, women are more likely to have obtained their asbestos exposure non-
occupationally, so estimating the future burden of disease based on past rates in women 
may inform future burden for the whole non-occupationally exposed population. In the 
same vein, prediction models could be tested for their accuracy by comparing their 
predicted cases against observed cases in women. 
Conclusion 
Future cases of asbestos-related disease have been predicted for a range of populations 
across many countries. The most robust methods incorporate direct measures of 
asbestos exposure, but this information is available only for defined occupational cohort 
studies, e.g. the Wittenoom crocidolite asbestos miners and millers. Other methods that 
use indirect measures of asbestos exposure, e.g. methods that assume asbestos exposure 
is proportional to asbestos imports or use, have predicted future cases of mesothelioma 
among workers with reasonable accuracy. Fewer studies have predicted cases of 
mesothelioma among populations with non-occupational asbestos exposure, and the 
robustness of these methods is less clear. Sufficient data about asbestos exposure may 
exist at a national level to permit an accurate prediction of future burden, but models 
using different estimates of exposure should be tested to examine the impact on the 
estimates of asbestos-related disease that may emerge from non-occupational asbestos 
exposure in the Australian population. 
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 Table 1. Summary of methods used to predict future cases of asbestos-related disease included in the review 
Study Disease 
predicted 
Population 
studied 
Prediction 
period 
Prediction method Asbestos exposure Model sensitivity tested w 
observed data (past 
mesothelioma/other cases)  
Model revisited to 
check accuracy of 
prediction 
Occupational cohorts 
Berry 1991 Mesothelioma, 
lung cancer and 
asbestosis 
Wittenoom 
workers 
1987–2020 Mesothelioma risk 
model 
Direct – cumulative 
exposure and time since 
first exposure 
Yes Yes – model that 
included 15% 
clearance of asbestos 
fibres from the lung 
was repeatedly a 
good fit 
National predictions – occupational exposure 
Peto 1995 Mesothelioma 
mortality 
Males in Great 
Britain 
1990–2040 Age-cohort model Indirect - asbestos 
consumption 
Yes Yes - model fit the 
data up to 1991, but 
did not fit younger 
cohorts 
Peto 1999 Mesothelioma 
mortality 
Males, Western 
Europe 
1995–2029 Age-cohort model none Yes Yes – was found to 
overestimate cases 
Banaei et al. 2000 Mesothelioma 
mortality 
French males 1997–2050 Risk function model 
that incorporated risk 
of death from 
mesothelioma as a 
function of past 
exposure 
Indirect – asbestos 
imports 
Yes No – but this method 
predicted similar 
numbers to an earlier 
APC model 
Segura et al. 2002 Mesothelioma 
mortality 
Males/females in 
the Netherlands 
2000–28 Age-cohort and age-
period-cohort models 
Indirect – asbestos 
consumption 
Yes No - This method 
predicted 44% fewer 
cases than earlier 
methods 
Marinaccio et al. 
2005 
Mesothelioma 
mortality 
Males in Italy 2012–24 Age-period-cohort 
model & asbestos 
consumption model 
Indirect -asbestos 
consumption 
Yes No 
Hodgson et al. 
2005 
Mesothelioma 
mortality 
Males in Great 
Britain 
2002–50 Poisson regression 
model 
Indirect; asbestos 
consumption 
Yes Yes, however this 
model has been 
subsequently 
enhanced 
 Study Disease 
predicted 
Population 
studied 
Prediction 
period 
Prediction method Asbestos exposure Model sensitivity tested w 
observed data (past 
mesothelioma/other cases)  
Model revisited to 
check accuracy of 
prediction 
Clements et al. 
2007 
Mesothelioma 
incidence 
Males in New 
South Wales, 
Australia 
2004–60 Age-cohort model 
and age/calendar year 
model similar to 
Hodgson et al.  
Indirect; asbestos 
consumption 
Yes No 
Pitarque et al. 
2008 
Mesothelioma 
mortality 
Spanish males 2002–17 Bayesian age-period-
cohort model  
Indirect; asbestos 
consumption 
Yes Later work showed a 
41% underestimate of 
cases from this 
method 
Tan et al. 2010 Mesothelioma 
mortality 
Males in Great 
Britain 
2007–50 Bayesian enhanced 
poisson regression 
model 
Indirect; age-specific 
exposure and overall 
population exposure 
Yes No  
Myojin et al. 2012 Mesothelioma 
mortality 
Japanese men with 
an occupational 
history of asbestos 
exposure 
2003–50 Risk function model 
that incorporated risk 
of death from 
mesothelioma as a 
function of past 
exposure 
Indirect; asbestos 
imports 
Yes No 
Lopez-Abente et 
al. 2013 
Pleural cancer 
(mesothelioma) 
deaths 
Spanish males and 
females 
2011–20 Age-period-cohort 
model 
Indirect; asbestos 
consumption 
Yes No 
Girardi et al. 2014 Mesothelioma 
incidence 
Males/females 
Veneto, Italy 
2011–26 Bayesian age-period-
cohort model 
Indirect; asbestos 
consumption 
Yes No 
Miranda et al. 
2015 
Mesothelioma 
mortality 
Males in Great 
Britain 
1990–40 Age-period-cohort 
model without offset 
None Yes No 
Soeberg et al. 
2016 
Mesothelioma 
incidence 
Males/females in 
Australia 
2012–30 Age-period-cohort 
model with natural 
cubic splines 
None; instead predicted 
incidence rates from 
historical trends 
Yes No 
Environmental exposure 
Azuma et al. 2009 Mesothelioma 
mortality 
Males/females in 
Japan 
2005–70 Mesothelioma risk 
model 
Indirect; historical 
asbestos exposure and 
mesothelioma rate 
attributed to 
environmental exposure 
Yes; model underestimated 
past cases 
No 
  
 
Study Disease 
predicted 
Population 
studied 
Prediction 
period 
Prediction method Asbestos exposure Model sensitivity tested w 
observed data (past 
mesothelioma/other cases)  
Model revisited to 
check accuracy of 
prediction 
Furlan et al. 2011 Mesothelioma 
mortality 
Population of the 
Casale Monferrato 
Local Health 
Area, Italy 
2008–40 Cellular Automata 
model (more 
commonly used in 
epidemic diseases) 
Indirect – based on 
number of people living 
in the LHA area at the 
same time 
Yes No 
Finity 2015 
(covers 
occupational and 
environmental 
exposure 
predictions) 
Mesothelioma 
incidence 
Australian 
population 
2015–2100 Mesothelioma 
risk model 
Indirect – asbestos 
volume index (equal to 
100% of asbestos 
consumed each year + 
30% of the asbestos 
removed each year 
Yes; back fit asbestos 
exposure allocation to cases 
from 1988 – by Wave of 
exposure  
No 
Other asbestos-related disease predictions 
dos Santos Antao 
et al. 2009 
Asbestosis 
mortality 
Males/females in 
United States of 
America 
2005–27 Generalised additive 
model 
Indirect; asbestos 
consumption 
Yes No 
Van der Bij et al 
.2016 
Lung cancer Males/females in 
the Netherlands 
2011–30 3 different models: 
1. Age-period-cohort 
model based on 
mesothelioma cases 
 
2. Past cases of lung 
cancer extrapolated 
forward 
3. Life table analysis 
1. Past mesothelioma 
cases used as a proxy 
for exposure 
2. Population 
Attributable Risk of 
asbestos exposure taken 
from earlier study 
3. JEM used to estimate 
current exposure 
Compared with an earlier 
Dutch study (Segura et al) 
method 1 estimated 20% 
higher number of cases 
No 
 
